Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: Potential impact in colorectal cancer.
about
Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma.ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.Polyunsaturated fatty acid-based targeted nanotherapeutics to enhance the therapeutic efficacy of docetaxel.Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.
P2860
Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: Potential impact in colorectal cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Preclinical and clinical studi ...... l impact in colorectal cancer.
@en
Preclinical and clinical studi ...... l impact in colorectal cancer.
@nl
type
label
Preclinical and clinical studi ...... l impact in colorectal cancer.
@en
Preclinical and clinical studi ...... l impact in colorectal cancer.
@nl
prefLabel
Preclinical and clinical studi ...... l impact in colorectal cancer.
@en
Preclinical and clinical studi ...... l impact in colorectal cancer.
@nl
P2093
P50
P1476
Preclinical and clinical studi ...... l impact in colorectal cancer.
@en
P2093
J B Vermorken
J Van den Bossche
V Deschoolmeester
P356
10.1016/J.PHARMTHERA.2016.06.014
P577
2016-06-29T00:00:00Z